advertisement

---

Journal of Ocular Pharmacology and Therapeutics 6

Showing records 1 to 6 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics

23515 Activities of angiotensin-converting enzymes ACE1 and ACE2 and inhibition by bioactive peptides in porcine ocular tissues
Luhtala S; Vaajanen A; Oksala O; Valjakka J; Vapaatalo H
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 23-28

---

23516 Potential benefit of intraocular pressure reduction in normal-tension glaucoma in South Korea
Je Seong G; Rho SH; Sik Kim C; Moon JI; Kook MS; Kim YY; Tak Ma K; Jae Hong Y; Nelson LA; Kruft B
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 91-96

---

23513 Mean target intraocular pressure and progression rates in chronic angle-closure glaucoma
Liza Sharmini AT; Yuen Shi Yin N; Shi-Huang Lee S; Jackson AL; Stewart WC
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 71-75

---

23517 The effect of prostaglandin analogs and prostamide on central corneal thickness
Hatanaka M; Vessani RM; Elias IR; Morita C; Susanna Jr R
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 51-53

---

23514 Efficacy and tolerability of latanoprost compared to dorzolamide combined with timolol in the treatment of patients with elevated intraocular pressure: A meta-analysis of randomized, controlled trials
Cheng J-W; Xi G-L; Wei R-L; Cai J-P; Li Y
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 55-64

---

23512 Pharmacotherapy compliance in patients with ocular hypertension or primary open-angle glaucoma
Traverso CE; Walt JG; Stern LS; Dolgitser M
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 77-82

---